Journal of Pharmacy and Pharmaceutical Research Open Access
Journal h-index: 5
Journal CiteScore: 0.94
Journal Impact Factor: 0.52
Average acceptance to publication time (5-7 days)
Average article processing time (30-45 days)
Less than 5 volumes 30 days
8 - 9 volumes 40 days
10 and more volumes 45 days
Reach us
+32 25889658
Abstract
Synthesis and Cytotoxic Screening of Fused Analogues of Dihydropyrimidinones against Hepg2 Cancer Cell Lines
Richard Soni, Ramandeep Kaur Brar, Rupinder Kaur Gill and Jitender Bariwal
10In the past decades, Biginelli-type dihydropyrimidones have received an extensive attention due to their interesting pharmacological properties with heterocyclic scaffolds. In this article, we have synthesized a series of fused analogues of Biginelli’s dihydropyrimidinone derivatives (RS-6 to RS-15). IC50 values of synthesized compounds against the proliferation of human hepato cellular carcinoma (HepG2) cell lines were determined through MTT assay. Compounds RS-10 (IC50=87 ± 0.2 μg/mL) & RS-15 (IC50=78 ± 3.7 μg/mL) showed most potent activity. Also compounds RS-7 (IC50=124 ± 3.2 μg/mL) & RS-12 (IC50=128 ± 1.9 μg/mL) showed significant cytotoxic activities against HepG2 cancer cell lines.
